nodes	percent_of_prediction	percent_of_DWPC	metapath
Lindane—GLRA2—Ion channel transport—FXYD6—hematologic cancer	0.00724	0.0357	CbGpPWpGaD
Lindane—GLRA3—Ion channel transport—FXYD6—hematologic cancer	0.00724	0.0357	CbGpPWpGaD
Lindane—GLRB—Ion channel transport—FXYD6—hematologic cancer	0.0059	0.0291	CbGpPWpGaD
Lindane—GLRA2—Ion channel transport—ATP1B1—hematologic cancer	0.00516	0.0254	CbGpPWpGaD
Lindane—GLRA3—Ion channel transport—ATP1B1—hematologic cancer	0.00516	0.0254	CbGpPWpGaD
Lindane—GLRA1—Ion channel transport—FXYD6—hematologic cancer	0.00467	0.023	CbGpPWpGaD
Lindane—GLRA3—Ion channel transport—ATP4A—hematologic cancer	0.00447	0.022	CbGpPWpGaD
Lindane—GLRA2—Ion channel transport—ATP4A—hematologic cancer	0.00447	0.022	CbGpPWpGaD
Lindane—GLRA2—Ion channel transport—SGK1—hematologic cancer	0.00447	0.022	CbGpPWpGaD
Lindane—GLRA3—Ion channel transport—SGK1—hematologic cancer	0.00447	0.022	CbGpPWpGaD
Lindane—GLRB—Ion channel transport—ATP1B1—hematologic cancer	0.00421	0.0207	CbGpPWpGaD
Lindane—GLRB—Ion channel transport—SGK1—hematologic cancer	0.00365	0.018	CbGpPWpGaD
Lindane—GLRB—Ion channel transport—ATP4A—hematologic cancer	0.00365	0.018	CbGpPWpGaD
Lindane—GLRA1—Ion channel transport—ATP1B1—hematologic cancer	0.00333	0.0164	CbGpPWpGaD
Lindane—GLRA1—Ion channel transport—SGK1—hematologic cancer	0.00288	0.0142	CbGpPWpGaD
Lindane—GLRA1—Ion channel transport—ATP4A—hematologic cancer	0.00288	0.0142	CbGpPWpGaD
Lindane—GLRA2—Transmembrane transport of small molecules—AQP9—hematologic cancer	0.00271	0.0134	CbGpPWpGaD
Lindane—GLRA3—Transmembrane transport of small molecules—AQP9—hematologic cancer	0.00271	0.0134	CbGpPWpGaD
Lindane—GLRA3—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.00252	0.0124	CbGpPWpGaD
Lindane—GLRA2—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.00252	0.0124	CbGpPWpGaD
Lindane—Dizziness—Clofarabine—hematologic cancer	0.00234	0.00293	CcSEcCtD
Lindane—Dizziness—Daunorubicin—hematologic cancer	0.00234	0.00293	CcSEcCtD
Lindane—Pruritus—Teniposide—hematologic cancer	0.00233	0.00293	CcSEcCtD
Lindane—Dizziness—Anagrelide—hematologic cancer	0.00233	0.00292	CcSEcCtD
Lindane—Dizziness—Pentostatin—hematologic cancer	0.00233	0.00292	CcSEcCtD
Lindane—Dermatitis—Methoxsalen—hematologic cancer	0.00232	0.00291	CcSEcCtD
Lindane—Headache—Methoxsalen—hematologic cancer	0.00231	0.0029	CcSEcCtD
Lindane—Urticaria—Dasatinib—hematologic cancer	0.00231	0.0029	CcSEcCtD
Lindane—Alopecia—Carmustine—hematologic cancer	0.00231	0.0029	CcSEcCtD
Lindane—Pain—Nilotinib—hematologic cancer	0.0023	0.00288	CcSEcCtD
Lindane—Alopecia—Alitretinoin—hematologic cancer	0.00229	0.00287	CcSEcCtD
Lindane—Pain—Imatinib—hematologic cancer	0.00228	0.00287	CcSEcCtD
Lindane—Convulsion—Bortezomib—hematologic cancer	0.00227	0.00285	CcSEcCtD
Lindane—Paraesthesia—Vinblastine—hematologic cancer	0.00226	0.00284	CcSEcCtD
Lindane—Alopecia—Ifosfamide—hematologic cancer	0.00226	0.00284	CcSEcCtD
Lindane—Dermatitis—Mercaptopurine—hematologic cancer	0.00226	0.00283	CcSEcCtD
Lindane—GABRB1—Orphan transporters—S100A10—hematologic cancer	0.00225	0.0111	CbGpPWpGaD
Lindane—Pain—Cladribine—hematologic cancer	0.00224	0.00282	CcSEcCtD
Lindane—Dermatitis contact—Epirubicin—hematologic cancer	0.00223	0.0028	CcSEcCtD
Lindane—Dermatitis—Daunorubicin—hematologic cancer	0.00223	0.00279	CcSEcCtD
Lindane—Dermatitis—Clofarabine—hematologic cancer	0.00223	0.00279	CcSEcCtD
Lindane—Dermatitis—Anagrelide—hematologic cancer	0.00222	0.00278	CcSEcCtD
Lindane—Dermatitis—Pentostatin—hematologic cancer	0.00222	0.00278	CcSEcCtD
Lindane—Headache—Daunorubicin—hematologic cancer	0.00221	0.00278	CcSEcCtD
Lindane—Headache—Clofarabine—hematologic cancer	0.00221	0.00278	CcSEcCtD
Lindane—GLRB—Transmembrane transport of small molecules—AQP9—hematologic cancer	0.00221	0.0109	CbGpPWpGaD
Lindane—Alopecia—Vincristine—hematologic cancer	0.0022	0.00276	CcSEcCtD
Lindane—Headache—Anagrelide—hematologic cancer	0.0022	0.00276	CcSEcCtD
Lindane—Headache—Pentostatin—hematologic cancer	0.0022	0.00276	CcSEcCtD
Lindane—Urticaria—Chlorambucil—hematologic cancer	0.00218	0.00274	CcSEcCtD
Lindane—Pruritus—Busulfan—hematologic cancer	0.00216	0.00271	CcSEcCtD
Lindane—Pain—Vinblastine—hematologic cancer	0.00215	0.0027	CcSEcCtD
Lindane—Paraesthesia—Melphalan—hematologic cancer	0.00215	0.0027	CcSEcCtD
Lindane—Alopecia—Mitoxantrone—hematologic cancer	0.00215	0.00269	CcSEcCtD
Lindane—Alopecia—Irinotecan—hematologic cancer	0.00215	0.00269	CcSEcCtD
Lindane—Dermatitis—Idarubicin—hematologic cancer	0.00214	0.00268	CcSEcCtD
Lindane—Urticaria—Nilotinib—hematologic cancer	0.00213	0.00268	CcSEcCtD
Lindane—Headache—Idarubicin—hematologic cancer	0.00212	0.00267	CcSEcCtD
Lindane—Urticaria—Imatinib—hematologic cancer	0.00212	0.00266	CcSEcCtD
Lindane—Convulsion—Thiotepa—hematologic cancer	0.00212	0.00266	CcSEcCtD
Lindane—Pruritus—Procarbazine—hematologic cancer	0.0021	0.00263	CcSEcCtD
Lindane—Paraesthesia—Lenalidomide—hematologic cancer	0.00209	0.00262	CcSEcCtD
Lindane—Alopecia—Gemcitabine—hematologic cancer	0.00209	0.00262	CcSEcCtD
Lindane—Urticaria—Cladribine—hematologic cancer	0.00209	0.00262	CcSEcCtD
Lindane—Dermatitis—Teniposide—hematologic cancer	0.00208	0.00261	CcSEcCtD
Lindane—Headache—Teniposide—hematologic cancer	0.00207	0.00259	CcSEcCtD
Lindane—Dermatitis contact—Doxorubicin—hematologic cancer	0.00206	0.00259	CcSEcCtD
Lindane—Pruritus—Dasatinib—hematologic cancer	0.00206	0.00258	CcSEcCtD
Lindane—Pruritus—Bexarotene—hematologic cancer	0.00206	0.00258	CcSEcCtD
Lindane—GLRB—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.00205	0.0101	CbGpPWpGaD
Lindane—GLRA3—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.00205	0.0101	CbGpPWpGaD
Lindane—GLRA2—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.00205	0.0101	CbGpPWpGaD
Lindane—Pruritus—Fludarabine—hematologic cancer	0.00205	0.00257	CcSEcCtD
Lindane—Convulsion—Thalidomide—hematologic cancer	0.00205	0.00257	CcSEcCtD
Lindane—Pain—Melphalan—hematologic cancer	0.00205	0.00257	CcSEcCtD
Lindane—Dizziness—Busulfan—hematologic cancer	0.00202	0.00254	CcSEcCtD
Lindane—Pain—Lenalidomide—hematologic cancer	0.00199	0.0025	CcSEcCtD
Lindane—Convulsion—Carmustine—hematologic cancer	0.00197	0.00247	CcSEcCtD
Lindane—Pain—Hydroxyurea—hematologic cancer	0.00196	0.00246	CcSEcCtD
Lindane—Dizziness—Procarbazine—hematologic cancer	0.00196	0.00246	CcSEcCtD
Lindane—Convulsion—Alitretinoin—hematologic cancer	0.00195	0.00245	CcSEcCtD
Lindane—Alopecia—Cisplatin—hematologic cancer	0.00195	0.00244	CcSEcCtD
Lindane—Pruritus—Chlorambucil—hematologic cancer	0.00194	0.00244	CcSEcCtD
Lindane—GABRB1—GABA receptor activation—ADCY7—hematologic cancer	0.00194	0.00955	CbGpPWpGaD
Lindane—GABRB1—Ion channel transport—FXYD6—hematologic cancer	0.00194	0.00954	CbGpPWpGaD
Lindane—Convulsion—Ifosfamide—hematologic cancer	0.00193	0.00242	CcSEcCtD
Lindane—Dermatitis—Busulfan—hematologic cancer	0.00193	0.00242	CcSEcCtD
Lindane—Paraesthesia—Bortezomib—hematologic cancer	0.00192	0.00241	CcSEcCtD
Lindane—Dizziness—Bexarotene—hematologic cancer	0.00192	0.00241	CcSEcCtD
Lindane—Dizziness—Dasatinib—hematologic cancer	0.00192	0.00241	CcSEcCtD
Lindane—Headache—Busulfan—hematologic cancer	0.00192	0.0024	CcSEcCtD
Lindane—GLRA2—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.00191	0.00941	CbGpPWpGaD
Lindane—GLRA3—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.00191	0.00941	CbGpPWpGaD
Lindane—Paraesthesia—Bleomycin—hematologic cancer	0.00191	0.0024	CcSEcCtD
Lindane—Urticaria—Melphalan—hematologic cancer	0.0019	0.00239	CcSEcCtD
Lindane—Pruritus—Nilotinib—hematologic cancer	0.0019	0.00239	CcSEcCtD
Lindane—Pruritus—Imatinib—hematologic cancer	0.00189	0.00237	CcSEcCtD
Lindane—Convulsion—Vincristine—hematologic cancer	0.00188	0.00236	CcSEcCtD
Lindane—Paraesthesia—Vinorelbine—hematologic cancer	0.00188	0.00236	CcSEcCtD
Lindane—Dermatitis—Procarbazine—hematologic cancer	0.00187	0.00234	CcSEcCtD
Lindane—Headache—Procarbazine—hematologic cancer	0.00186	0.00233	CcSEcCtD
Lindane—Pruritus—Cladribine—hematologic cancer	0.00186	0.00233	CcSEcCtD
Lindane—Urticaria—Lenalidomide—hematologic cancer	0.00185	0.00232	CcSEcCtD
Lindane—Pain—Bortezomib—hematologic cancer	0.00183	0.0023	CcSEcCtD
Lindane—Dermatitis—Bexarotene—hematologic cancer	0.00183	0.0023	CcSEcCtD
Lindane—Dermatitis—Dasatinib—hematologic cancer	0.00183	0.0023	CcSEcCtD
Lindane—Convulsion—Mitoxantrone—hematologic cancer	0.00183	0.0023	CcSEcCtD
Lindane—Dermatitis—Fludarabine—hematologic cancer	0.00183	0.00229	CcSEcCtD
Lindane—Headache—Dasatinib—hematologic cancer	0.00182	0.00229	CcSEcCtD
Lindane—Headache—Bexarotene—hematologic cancer	0.00182	0.00229	CcSEcCtD
Lindane—Pain—Bleomycin—hematologic cancer	0.00182	0.00228	CcSEcCtD
Lindane—Headache—Fludarabine—hematologic cancer	0.00182	0.00228	CcSEcCtD
Lindane—GLRA2—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.0018	0.00884	CbGpPWpGaD
Lindane—GLRA3—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.0018	0.00884	CbGpPWpGaD
Lindane—Paraesthesia—Thiotepa—hematologic cancer	0.00179	0.00225	CcSEcCtD
Lindane—Pain—Vinorelbine—hematologic cancer	0.00179	0.00224	CcSEcCtD
Lindane—Alopecia—Etoposide—hematologic cancer	0.00178	0.00224	CcSEcCtD
Lindane—Dizziness—Nilotinib—hematologic cancer	0.00178	0.00223	CcSEcCtD
Lindane—Dizziness—Imatinib—hematologic cancer	0.00177	0.00222	CcSEcCtD
Lindane—GLRA1—Transmembrane transport of small molecules—AQP9—hematologic cancer	0.00175	0.0086	CbGpPWpGaD
Lindane—Dizziness—Cladribine—hematologic cancer	0.00174	0.00218	CcSEcCtD
Lindane—Paraesthesia—Thalidomide—hematologic cancer	0.00174	0.00218	CcSEcCtD
Lindane—Pain—Thiotepa—hematologic cancer	0.00171	0.00214	CcSEcCtD
Lindane—GABRB1—Orphan transporters—ANXA2—hematologic cancer	0.00171	0.0084	CbGpPWpGaD
Lindane—GLRA2—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.0017	0.00838	CbGpPWpGaD
Lindane—GLRA3—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.0017	0.00838	CbGpPWpGaD
Lindane—Urticaria—Bortezomib—hematologic cancer	0.0017	0.00214	CcSEcCtD
Lindane—Pruritus—Melphalan—hematologic cancer	0.00169	0.00213	CcSEcCtD
Lindane—Dermatitis—Nilotinib—hematologic cancer	0.00169	0.00212	CcSEcCtD
Lindane—Urticaria—Bleomycin—hematologic cancer	0.00169	0.00212	CcSEcCtD
Lindane—Headache—Nilotinib—hematologic cancer	0.00168	0.00211	CcSEcCtD
Lindane—Dermatitis—Imatinib—hematologic cancer	0.00168	0.00211	CcSEcCtD
Lindane—GLRB—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.00167	0.00825	CbGpPWpGaD
Lindane—Headache—Imatinib—hematologic cancer	0.00167	0.0021	CcSEcCtD
Lindane—Paraesthesia—Carmustine—hematologic cancer	0.00167	0.00209	CcSEcCtD
Lindane—Dizziness—Vinblastine—hematologic cancer	0.00166	0.00209	CcSEcCtD
Lindane—Convulsion—Cisplatin—hematologic cancer	0.00166	0.00209	CcSEcCtD
Lindane—Urticaria—Vinorelbine—hematologic cancer	0.00166	0.00209	CcSEcCtD
Lindane—Dermatitis—Cladribine—hematologic cancer	0.00165	0.00207	CcSEcCtD
Lindane—Pain—Thalidomide—hematologic cancer	0.00165	0.00207	CcSEcCtD
Lindane—Paraesthesia—Alitretinoin—hematologic cancer	0.00165	0.00207	CcSEcCtD
Lindane—Pruritus—Lenalidomide—hematologic cancer	0.00165	0.00207	CcSEcCtD
Lindane—Headache—Cladribine—hematologic cancer	0.00164	0.00206	CcSEcCtD
Lindane—Paraesthesia—Ifosfamide—hematologic cancer	0.00163	0.00205	CcSEcCtD
Lindane—GLRA1—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.00162	0.008	CbGpPWpGaD
Lindane—Paraesthesia—Vincristine—hematologic cancer	0.00159	0.002	CcSEcCtD
Lindane—Urticaria—Thiotepa—hematologic cancer	0.00159	0.00199	CcSEcCtD
Lindane—Pain—Carmustine—hematologic cancer	0.00159	0.00199	CcSEcCtD
Lindane—Headache—Vinblastine—hematologic cancer	0.00158	0.00198	CcSEcCtD
Lindane—Pain—Alitretinoin—hematologic cancer	0.00157	0.00197	CcSEcCtD
Lindane—GLRB—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.00156	0.00767	CbGpPWpGaD
Lindane—GLRA3—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.00156	0.00767	CbGpPWpGaD
Lindane—GLRA3—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.00156	0.00767	CbGpPWpGaD
Lindane—GLRA3—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.00156	0.00767	CbGpPWpGaD
Lindane—GLRA2—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.00156	0.00767	CbGpPWpGaD
Lindane—GLRA2—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.00156	0.00767	CbGpPWpGaD
Lindane—GLRA2—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.00156	0.00767	CbGpPWpGaD
Lindane—Pain—Ifosfamide—hematologic cancer	0.00155	0.00195	CcSEcCtD
Lindane—Paraesthesia—Irinotecan—hematologic cancer	0.00155	0.00194	CcSEcCtD
Lindane—Paraesthesia—Mitoxantrone—hematologic cancer	0.00155	0.00194	CcSEcCtD
Lindane—Dizziness—Lenalidomide—hematologic cancer	0.00154	0.00193	CcSEcCtD
Lindane—GABRB1—Orphan transporters—TUBB2A—hematologic cancer	0.00154	0.00757	CbGpPWpGaD
Lindane—Urticaria—Thalidomide—hematologic cancer	0.00154	0.00193	CcSEcCtD
Lindane—Convulsion—Etoposide—hematologic cancer	0.00152	0.00191	CcSEcCtD
Lindane—Dizziness—Hydroxyurea—hematologic cancer	0.00152	0.0019	CcSEcCtD
Lindane—Pruritus—Bortezomib—hematologic cancer	0.00152	0.0019	CcSEcCtD
Lindane—Pain—Vincristine—hematologic cancer	0.00151	0.0019	CcSEcCtD
Lindane—Paraesthesia—Gemcitabine—hematologic cancer	0.00151	0.00189	CcSEcCtD
Lindane—Dermatitis—Melphalan—hematologic cancer	0.00151	0.00189	CcSEcCtD
Lindane—Pruritus—Bleomycin—hematologic cancer	0.0015	0.00189	CcSEcCtD
Lindane—Convulsion—Prednisolone—hematologic cancer	0.0015	0.00189	CcSEcCtD
Lindane—Pruritus—Vinorelbine—hematologic cancer	0.00148	0.00186	CcSEcCtD
Lindane—Pain—Mitoxantrone—hematologic cancer	0.00148	0.00185	CcSEcCtD
Lindane—Pain—Irinotecan—hematologic cancer	0.00148	0.00185	CcSEcCtD
Lindane—Alopecia—Dexamethasone—hematologic cancer	0.00147	0.00184	CcSEcCtD
Lindane—Alopecia—Betamethasone—hematologic cancer	0.00147	0.00184	CcSEcCtD
Lindane—Dermatitis—Lenalidomide—hematologic cancer	0.00147	0.00184	CcSEcCtD
Lindane—GLRB—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.00146	0.00721	CbGpPWpGaD
Lindane—Urticaria—Alitretinoin—hematologic cancer	0.00146	0.00183	CcSEcCtD
Lindane—Headache—Lenalidomide—hematologic cancer	0.00146	0.00183	CcSEcCtD
Lindane—Dermatitis—Hydroxyurea—hematologic cancer	0.00145	0.00181	CcSEcCtD
Lindane—Urticaria—Ifosfamide—hematologic cancer	0.00144	0.00181	CcSEcCtD
Lindane—Headache—Hydroxyurea—hematologic cancer	0.00144	0.0018	CcSEcCtD
Lindane—Pain—Gemcitabine—hematologic cancer	0.00144	0.0018	CcSEcCtD
Lindane—Dizziness—Bortezomib—hematologic cancer	0.00142	0.00178	CcSEcCtD
Lindane—Pruritus—Thiotepa—hematologic cancer	0.00141	0.00177	CcSEcCtD
Lindane—Paraesthesia—Cisplatin—hematologic cancer	0.00141	0.00177	CcSEcCtD
Lindane—GLRA3—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.0014	0.0069	CbGpPWpGaD
Lindane—GLRA2—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.0014	0.0069	CbGpPWpGaD
Lindane—GLRB—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.00139	0.00683	CbGpPWpGaD
Lindane—Dizziness—Vinorelbine—hematologic cancer	0.00138	0.00174	CcSEcCtD
Lindane—Convulsion—Triamcinolone—hematologic cancer	0.00138	0.00173	CcSEcCtD
Lindane—GABRB1—Ion channel transport—ATP1B1—hematologic cancer	0.00138	0.0068	CbGpPWpGaD
Lindane—Urticaria—Mitoxantrone—hematologic cancer	0.00137	0.00172	CcSEcCtD
Lindane—Pruritus—Thalidomide—hematologic cancer	0.00137	0.00172	CcSEcCtD
Lindane—Dermatitis—Bortezomib—hematologic cancer	0.00135	0.00169	CcSEcCtD
Lindane—Headache—Bortezomib—hematologic cancer	0.00134	0.00168	CcSEcCtD
Lindane—Pain—Cisplatin—hematologic cancer	0.00134	0.00168	CcSEcCtD
Lindane—Dermatitis—Bleomycin—hematologic cancer	0.00134	0.00168	CcSEcCtD
Lindane—GLRA1—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.00132	0.00652	CbGpPWpGaD
Lindane—Dizziness—Thiotepa—hematologic cancer	0.00132	0.00166	CcSEcCtD
Lindane—Dermatitis—Vinorelbine—hematologic cancer	0.00132	0.00165	CcSEcCtD
Lindane—Headache—Vinorelbine—hematologic cancer	0.00131	0.00164	CcSEcCtD
Lindane—Pruritus—Alitretinoin—hematologic cancer	0.0013	0.00163	CcSEcCtD
Lindane—Paraesthesia—Etoposide—hematologic cancer	0.00129	0.00162	CcSEcCtD
Lindane—Pruritus—Ifosfamide—hematologic cancer	0.00129	0.00161	CcSEcCtD
Lindane—Alopecia—Prednisone—hematologic cancer	0.00128	0.00161	CcSEcCtD
Lindane—Dizziness—Thalidomide—hematologic cancer	0.00128	0.0016	CcSEcCtD
Lindane—Paraesthesia—Prednisolone—hematologic cancer	0.00127	0.00159	CcSEcCtD
Lindane—GLRB—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.00127	0.00625	CbGpPWpGaD
Lindane—GLRB—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.00127	0.00625	CbGpPWpGaD
Lindane—GLRB—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.00127	0.00625	CbGpPWpGaD
Lindane—Dermatitis—Thiotepa—hematologic cancer	0.00126	0.00158	CcSEcCtD
Lindane—Convulsion—Dexamethasone—hematologic cancer	0.00125	0.00157	CcSEcCtD
Lindane—Convulsion—Betamethasone—hematologic cancer	0.00125	0.00157	CcSEcCtD
Lindane—Headache—Thiotepa—hematologic cancer	0.00125	0.00157	CcSEcCtD
Lindane—GLRA1—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.00123	0.00606	CbGpPWpGaD
Lindane—GLRA3—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.00123	0.00606	CbGpPWpGaD
Lindane—GLRA2—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.00123	0.00606	CbGpPWpGaD
Lindane—Dizziness—Carmustine—hematologic cancer	0.00123	0.00154	CcSEcCtD
Lindane—Pain—Etoposide—hematologic cancer	0.00123	0.00154	CcSEcCtD
Lindane—Dermatitis—Thalidomide—hematologic cancer	0.00122	0.00153	CcSEcCtD
Lindane—Dizziness—Alitretinoin—hematologic cancer	0.00122	0.00153	CcSEcCtD
Lindane—Headache—Thalidomide—hematologic cancer	0.00121	0.00152	CcSEcCtD
Lindane—Pain—Prednisolone—hematologic cancer	0.00121	0.00152	CcSEcCtD
Lindane—Dizziness—Ifosfamide—hematologic cancer	0.0012	0.00151	CcSEcCtD
Lindane—GABRB1—Ion channel transport—SGK1—hematologic cancer	0.0012	0.0059	CbGpPWpGaD
Lindane—GABRB1—Ion channel transport—ATP4A—hematologic cancer	0.0012	0.0059	CbGpPWpGaD
Lindane—Pruritus—Gemcitabine—hematologic cancer	0.00119	0.00149	CcSEcCtD
Lindane—Dizziness—Vincristine—hematologic cancer	0.00117	0.00147	CcSEcCtD
Lindane—Dermatitis—Carmustine—hematologic cancer	0.00117	0.00147	CcSEcCtD
Lindane—Paraesthesia—Triamcinolone—hematologic cancer	0.00117	0.00147	CcSEcCtD
Lindane—Headache—Carmustine—hematologic cancer	0.00116	0.00146	CcSEcCtD
Lindane—Dermatitis—Alitretinoin—hematologic cancer	0.00116	0.00145	CcSEcCtD
Lindane—GLRA1—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.00116	0.0057	CbGpPWpGaD
Lindane—Headache—Alitretinoin—hematologic cancer	0.00115	0.00145	CcSEcCtD
Lindane—Dermatitis—Ifosfamide—hematologic cancer	0.00114	0.00144	CcSEcCtD
Lindane—GLRB—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.00114	0.00563	CbGpPWpGaD
Lindane—Dizziness—Irinotecan—hematologic cancer	0.00114	0.00143	CcSEcCtD
Lindane—Urticaria—Etoposide—hematologic cancer	0.00114	0.00143	CcSEcCtD
Lindane—GLRA2—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.00113	0.00554	CbGpPWpGaD
Lindane—GLRA3—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.00113	0.00554	CbGpPWpGaD
Lindane—Urticaria—Prednisolone—hematologic cancer	0.00112	0.00141	CcSEcCtD
Lindane—Dermatitis—Vincristine—hematologic cancer	0.00112	0.0014	CcSEcCtD
Lindane—Pain—Triamcinolone—hematologic cancer	0.00111	0.0014	CcSEcCtD
Lindane—Headache—Vincristine—hematologic cancer	0.00111	0.00139	CcSEcCtD
Lindane—GLRA1—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.0011	0.0054	CbGpPWpGaD
Lindane—Convulsion—Prednisone—hematologic cancer	0.00109	0.00137	CcSEcCtD
Lindane—Dermatitis—Irinotecan—hematologic cancer	0.00109	0.00136	CcSEcCtD
Lindane—Dermatitis—Mitoxantrone—hematologic cancer	0.00109	0.00136	CcSEcCtD
Lindane—Headache—Mitoxantrone—hematologic cancer	0.00108	0.00136	CcSEcCtD
Lindane—Headache—Irinotecan—hematologic cancer	0.00108	0.00136	CcSEcCtD
Lindane—Alopecia—Methotrexate—hematologic cancer	0.00107	0.00134	CcSEcCtD
Lindane—GLRA3—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.00106	0.00523	CbGpPWpGaD
Lindane—GLRA2—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.00106	0.00523	CbGpPWpGaD
Lindane—Paraesthesia—Betamethasone—hematologic cancer	0.00106	0.00133	CcSEcCtD
Lindane—Paraesthesia—Dexamethasone—hematologic cancer	0.00106	0.00133	CcSEcCtD
Lindane—Dermatitis—Gemcitabine—hematologic cancer	0.00106	0.00133	CcSEcCtD
Lindane—Headache—Gemcitabine—hematologic cancer	0.00105	0.00132	CcSEcCtD
Lindane—Urticaria—Triamcinolone—hematologic cancer	0.00103	0.0013	CcSEcCtD
Lindane—GLRA3—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.00103	0.00508	CbGpPWpGaD
Lindane—GLRA2—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.00103	0.00508	CbGpPWpGaD
Lindane—GLRA3—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.00102	0.00504	CbGpPWpGaD
Lindane—GLRA2—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.00102	0.00504	CbGpPWpGaD
Lindane—Pruritus—Etoposide—hematologic cancer	0.00102	0.00127	CcSEcCtD
Lindane—Pain—Betamethasone—hematologic cancer	0.00101	0.00127	CcSEcCtD
Lindane—Pain—Dexamethasone—hematologic cancer	0.00101	0.00127	CcSEcCtD
Lindane—GLRA1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.001	0.00494	CbGpPWpGaD
Lindane—GLRB—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.001	0.00494	CbGpPWpGaD
Lindane—GLRA1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.001	0.00494	CbGpPWpGaD
Lindane—GLRA1—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.001	0.00494	CbGpPWpGaD
Lindane—GLRA2—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.001	0.00494	CbGpPWpGaD
Lindane—GLRA3—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.001	0.00494	CbGpPWpGaD
Lindane—Alopecia—Epirubicin—hematologic cancer	0.001	0.00126	CcSEcCtD
Lindane—Dermatitis—Cisplatin—hematologic cancer	0.000987	0.00124	CcSEcCtD
Lindane—Dizziness—Etoposide—hematologic cancer	0.000949	0.00119	CcSEcCtD
Lindane—Urticaria—Betamethasone—hematologic cancer	0.000938	0.00118	CcSEcCtD
Lindane—Urticaria—Dexamethasone—hematologic cancer	0.000938	0.00118	CcSEcCtD
Lindane—Dizziness—Prednisolone—hematologic cancer	0.000936	0.00117	CcSEcCtD
Lindane—Alopecia—Doxorubicin—hematologic cancer	0.000926	0.00116	CcSEcCtD
Lindane—Paraesthesia—Prednisone—hematologic cancer	0.000924	0.00116	CcSEcCtD
Lindane—Pruritus—Triamcinolone—hematologic cancer	0.000921	0.00116	CcSEcCtD
Lindane—GLRB—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.000918	0.00452	CbGpPWpGaD
Lindane—Convulsion—Methotrexate—hematologic cancer	0.000913	0.00115	CcSEcCtD
Lindane—Dermatitis—Etoposide—hematologic cancer	0.000904	0.00113	CcSEcCtD
Lindane—GLRA1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.000903	0.00445	CbGpPWpGaD
Lindane—Headache—Etoposide—hematologic cancer	0.000899	0.00113	CcSEcCtD
Lindane—GLRA2—Transmembrane transport of small molecules—TFRC—hematologic cancer	0.000894	0.0044	CbGpPWpGaD
Lindane—GLRA3—Transmembrane transport of small molecules—TFRC—hematologic cancer	0.000894	0.0044	CbGpPWpGaD
Lindane—Dermatitis—Prednisolone—hematologic cancer	0.000892	0.00112	CcSEcCtD
Lindane—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY7—hematologic cancer	0.000891	0.00439	CbGpPWpGaD
Lindane—Headache—Prednisolone—hematologic cancer	0.000887	0.00111	CcSEcCtD
Lindane—GLRB—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.000866	0.00427	CbGpPWpGaD
Lindane—Dizziness—Triamcinolone—hematologic cancer	0.000861	0.00108	CcSEcCtD
Lindane—Convulsion—Epirubicin—hematologic cancer	0.000854	0.00107	CcSEcCtD
Lindane—GLRB—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.000841	0.00414	CbGpPWpGaD
Lindane—Pruritus—Dexamethasone—hematologic cancer	0.000836	0.00105	CcSEcCtD
Lindane—Pruritus—Betamethasone—hematologic cancer	0.000836	0.00105	CcSEcCtD
Lindane—GLRB—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.000835	0.00411	CbGpPWpGaD
Lindane—GABRB1—Orphan transporters—CYCS—hematologic cancer	0.000823	0.00405	CbGpPWpGaD
Lindane—Dermatitis—Triamcinolone—hematologic cancer	0.00082	0.00103	CcSEcCtD
Lindane—GLRB—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.000818	0.00403	CbGpPWpGaD
Lindane—Urticaria—Prednisone—hematologic cancer	0.000817	0.00103	CcSEcCtD
Lindane—Headache—Triamcinolone—hematologic cancer	0.000815	0.00102	CcSEcCtD
Lindane—GLRA1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.000793	0.00391	CbGpPWpGaD
Lindane—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—hematologic cancer	0.000793	0.0039	CbGpPWpGaD
Lindane—Convulsion—Doxorubicin—hematologic cancer	0.00079	0.000992	CcSEcCtD
Lindane—Dizziness—Dexamethasone—hematologic cancer	0.000781	0.00098	CcSEcCtD
Lindane—Dizziness—Betamethasone—hematologic cancer	0.000781	0.00098	CcSEcCtD
Lindane—Paraesthesia—Methotrexate—hematologic cancer	0.000772	0.000969	CcSEcCtD
Lindane—GLRA2—Transmembrane transport of small molecules—CYCS—hematologic cancer	0.000751	0.0037	CbGpPWpGaD
Lindane—GLRA3—Transmembrane transport of small molecules—CYCS—hematologic cancer	0.000751	0.0037	CbGpPWpGaD
Lindane—Dermatitis—Betamethasone—hematologic cancer	0.000744	0.000934	CcSEcCtD
Lindane—Dermatitis—Dexamethasone—hematologic cancer	0.000744	0.000934	CcSEcCtD
Lindane—Headache—Dexamethasone—hematologic cancer	0.00074	0.000928	CcSEcCtD
Lindane—Headache—Betamethasone—hematologic cancer	0.00074	0.000928	CcSEcCtD
Lindane—Pain—Methotrexate—hematologic cancer	0.000735	0.000922	CcSEcCtD
Lindane—GABRB1—Transmission across Chemical Synapses—SLC22A1—hematologic cancer	0.000731	0.0036	CbGpPWpGaD
Lindane—GLRB—Transmembrane transport of small molecules—TFRC—hematologic cancer	0.000729	0.00359	CbGpPWpGaD
Lindane—Pruritus—Prednisone—hematologic cancer	0.000728	0.000913	CcSEcCtD
Lindane—GABRB1—Transmembrane transport of small molecules—AQP9—hematologic cancer	0.000725	0.00357	CbGpPWpGaD
Lindane—GLRA1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.000725	0.00357	CbGpPWpGaD
Lindane—Paraesthesia—Epirubicin—hematologic cancer	0.000722	0.000906	CcSEcCtD
Lindane—Pain—Epirubicin—hematologic cancer	0.000688	0.000863	CcSEcCtD
Lindane—GLRA1—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.000685	0.00337	CbGpPWpGaD
Lindane—Urticaria—Methotrexate—hematologic cancer	0.000683	0.000857	CcSEcCtD
Lindane—Dizziness—Prednisone—hematologic cancer	0.00068	0.000853	CcSEcCtD
Lindane—GABRB1—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.000674	0.00332	CbGpPWpGaD
Lindane—GABRB1—Transmission across Chemical Synapses—ADCY7—hematologic cancer	0.00067	0.0033	CbGpPWpGaD
Lindane—Paraesthesia—Doxorubicin—hematologic cancer	0.000668	0.000839	CcSEcCtD
Lindane—GLRA1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.000665	0.00327	CbGpPWpGaD
Lindane—GLRA1—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.00066	0.00325	CbGpPWpGaD
Lindane—Dermatitis—Prednisone—hematologic cancer	0.000648	0.000813	CcSEcCtD
Lindane—GLRA1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.000647	0.00318	CbGpPWpGaD
Lindane—Headache—Prednisone—hematologic cancer	0.000644	0.000809	CcSEcCtD
Lindane—Urticaria—Epirubicin—hematologic cancer	0.000639	0.000802	CcSEcCtD
Lindane—Pain—Doxorubicin—hematologic cancer	0.000637	0.000799	CcSEcCtD
Lindane—GLRA3—Transmembrane transport of small molecules—ABCB1—hematologic cancer	0.000626	0.00308	CbGpPWpGaD
Lindane—GLRA2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	0.000626	0.00308	CbGpPWpGaD
Lindane—GLRB—Transmembrane transport of small molecules—CYCS—hematologic cancer	0.000612	0.00301	CbGpPWpGaD
Lindane—Pruritus—Methotrexate—hematologic cancer	0.000608	0.000763	CcSEcCtD
Lindane—GABRB1—Transmission across Chemical Synapses—CAMK2D—hematologic cancer	0.000596	0.00294	CbGpPWpGaD
Lindane—Urticaria—Doxorubicin—hematologic cancer	0.000591	0.000742	CcSEcCtD
Lindane—GLRA1—Transmembrane transport of small molecules—TFRC—hematologic cancer	0.000576	0.00284	CbGpPWpGaD
Lindane—Pruritus—Epirubicin—hematologic cancer	0.000569	0.000714	CcSEcCtD
Lindane—Dizziness—Methotrexate—hematologic cancer	0.000568	0.000713	CcSEcCtD
Lindane—GABRB1—Neuronal System—SLC22A1—hematologic cancer	0.00056	0.00276	CbGpPWpGaD
Lindane—GABRB1—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.00055	0.00271	CbGpPWpGaD
Lindane—Dermatitis—Methotrexate—hematologic cancer	0.000542	0.000679	CcSEcCtD
Lindane—Headache—Methotrexate—hematologic cancer	0.000539	0.000676	CcSEcCtD
Lindane—Dizziness—Epirubicin—hematologic cancer	0.000532	0.000668	CcSEcCtD
Lindane—Pruritus—Doxorubicin—hematologic cancer	0.000527	0.000661	CcSEcCtD
Lindane—GABRB1—Neuronal System—ADCY7—hematologic cancer	0.000513	0.00253	CbGpPWpGaD
Lindane—GABRB1—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.000511	0.00252	CbGpPWpGaD
Lindane—GLRB—Transmembrane transport of small molecules—ABCB1—hematologic cancer	0.00051	0.00251	CbGpPWpGaD
Lindane—Dermatitis—Epirubicin—hematologic cancer	0.000507	0.000636	CcSEcCtD
Lindane—Headache—Epirubicin—hematologic cancer	0.000504	0.000632	CcSEcCtD
Lindane—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCG—hematologic cancer	0.000501	0.00247	CbGpPWpGaD
Lindane—Dizziness—Doxorubicin—hematologic cancer	0.000492	0.000618	CcSEcCtD
Lindane—GLRA1—Transmembrane transport of small molecules—CYCS—hematologic cancer	0.000484	0.00238	CbGpPWpGaD
Lindane—GABRB1—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.000481	0.00237	CbGpPWpGaD
Lindane—Dermatitis—Doxorubicin—hematologic cancer	0.000469	0.000588	CcSEcCtD
Lindane—Headache—Doxorubicin—hematologic cancer	0.000466	0.000585	CcSEcCtD
Lindane—GABRB1—Orphan transporters—CREBBP—hematologic cancer	0.000459	0.00226	CbGpPWpGaD
Lindane—GABRB1—Neuronal System—CAMK2D—hematologic cancer	0.000457	0.00225	CbGpPWpGaD
Lindane—GABRB1—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.000456	0.00224	CbGpPWpGaD
Lindane—GLRA2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	0.000419	0.00206	CbGpPWpGaD
Lindane—GLRA3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	0.000419	0.00206	CbGpPWpGaD
Lindane—GABRB1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.000417	0.00205	CbGpPWpGaD
Lindane—GABRB1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.000417	0.00205	CbGpPWpGaD
Lindane—GABRB1—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.000417	0.00205	CbGpPWpGaD
Lindane—GLRA1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	0.000404	0.00199	CbGpPWpGaD
Lindane—GLRA2—Transmembrane transport of small molecules—ALB—hematologic cancer	0.000392	0.00193	CbGpPWpGaD
Lindane—GLRA3—Transmembrane transport of small molecules—ALB—hematologic cancer	0.000392	0.00193	CbGpPWpGaD
Lindane—GABRB1—Transmission across Chemical Synapses—PRKCG—hematologic cancer	0.000377	0.00186	CbGpPWpGaD
Lindane—GABRB1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.000375	0.00185	CbGpPWpGaD
Lindane—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—hematologic cancer	0.000371	0.00183	CbGpPWpGaD
Lindane—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—hematologic cancer	0.000367	0.00181	CbGpPWpGaD
Lindane—GLRB—Transmembrane transport of small molecules—CREBBP—hematologic cancer	0.000341	0.00168	CbGpPWpGaD
Lindane—GABRB1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.000329	0.00162	CbGpPWpGaD
Lindane—GLRB—Transmembrane transport of small molecules—ALB—hematologic cancer	0.000319	0.00157	CbGpPWpGaD
Lindane—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—hematologic cancer	0.000307	0.00151	CbGpPWpGaD
Lindane—GABRB1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.000301	0.00148	CbGpPWpGaD
Lindane—GABRB1—Neuronal System—PRKCG—hematologic cancer	0.000289	0.00142	CbGpPWpGaD
Lindane—GABRB1—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.000284	0.0014	CbGpPWpGaD
Lindane—GABRB1—Transmission across Chemical Synapses—CREB1—hematologic cancer	0.000279	0.00137	CbGpPWpGaD
Lindane—GABRB1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.000276	0.00136	CbGpPWpGaD
Lindane—GABRB1—Transmission across Chemical Synapses—BRAF—hematologic cancer	0.000276	0.00136	CbGpPWpGaD
Lindane—GABRB1—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.000274	0.00135	CbGpPWpGaD
Lindane—GLRA1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	0.00027	0.00133	CbGpPWpGaD
Lindane—GABRB1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.000268	0.00132	CbGpPWpGaD
Lindane—GLRA1—Transmembrane transport of small molecules—ALB—hematologic cancer	0.000252	0.00124	CbGpPWpGaD
Lindane—GABRB1—Transmembrane transport of small molecules—TFRC—hematologic cancer	0.000239	0.00118	CbGpPWpGaD
Lindane—GABRB1—Transmission across Chemical Synapses—MDM2—hematologic cancer	0.000231	0.00114	CbGpPWpGaD
Lindane—GABRB1—Neuronal System—CREB1—hematologic cancer	0.000214	0.00105	CbGpPWpGaD
Lindane—GABRB1—Neuronal System—BRAF—hematologic cancer	0.000211	0.00104	CbGpPWpGaD
Lindane—GABRB1—Transmembrane transport of small molecules—CYCS—hematologic cancer	0.000201	0.000989	CbGpPWpGaD
Lindane—GABRB1—Neuronal System—MDM2—hematologic cancer	0.000177	0.000871	CbGpPWpGaD
Lindane—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	0.000169	0.00083	CbGpPWpGaD
Lindane—GABRB1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	0.000168	0.000825	CbGpPWpGaD
Lindane—GABRB1—Transmission across Chemical Synapses—HRAS—hematologic cancer	0.000127	0.000624	CbGpPWpGaD
Lindane—GABRB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	0.000112	0.000551	CbGpPWpGaD
Lindane—GABRB1—Transmembrane transport of small molecules—ALB—hematologic cancer	0.000105	0.000516	CbGpPWpGaD
Lindane—GABRB1—Neuronal System—HRAS—hematologic cancer	9.71e-05	0.000478	CbGpPWpGaD
